Study compares after-effects of prostatectomy, active surveillance, radiation, hormone therapy for prostate cancer
Estimates of long-term bowel, bladder, and sexual function after localized prostate cancer treatment may enable men to make informed choices about care, the authors said.
28 Jan 2020
Joseph R. Mikhael, MD, FACP, reviewed practical approaches to two premalignant conditions, monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL).
1 Jul 2023
The authors recommended against routine screening with this method in primary care to minimize unnecessary diagnostic testing, overdiagnosis, and overtreatment.
20 Mar 2018
This column reviews recent recalls, alerts, and approvals.
1 Sep 2023
This free activity is recommended for physicians who have limited experience in practice assessment or are new to the health care quality improvement process, and is eligible for up to 20 CME credits and 20 Maintenance of Certification Practice Assessment points.
3 Jul 2018
Prostate cancer requires men to work through a multitude of treatment options, and if the patient ends up settling on active surveillance, then the internist's role is even more important moving forward.
1 Nov 2017
Use of active surveillance or watchful waiting for prostate cancer rose from 2010 to 2018, although uptake was lower in men with multiple positive biopsy cores and those who were Asian/Pacific Islander and Hispanic, had a lower income, or lived in a rural area.
11 Apr 2023
Data were collected from a nationwide Danish registry on tumor characteristics, drug use, primary prostate cancer therapy, comorbid conditions, and socioeconomic variables for men with incident prostate adenocarcinoma between 2000 and 2011.
5 Mar 2019
An expert clears up issues surrounding prostate cancer screening recommendations at Internal Medicine Meeting 2022.
1 Jul 2022
Prostate-specific antigen-based screening programs in men ages 55 to 69 years may prevent approximately 1.3 deaths from prostate cancer over approximately 13 years per 1,000 men screened, as well as approximately three cases of metastatic prostate cancer per 1,000 men screened, the U.S. Preventive Services Task Force (USPSTF) found.
15 May 2018